英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
kras查看　kras　在百度字典中的解释百度英翻中〔查看〕
kras查看　kras　在Google字典中的解释Google英翻中〔查看〕
kras查看　kras　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • KRAS - Wikipedia
    KRAS (Kirsten rat sarcoma virus oncogene homologue) is a gene that provides instructions for making a protein called K-Ras, a part of the RAS MAPK pathway The protein relays signals from outside the cell to the cell's nucleus
  • What’s new in KRAS mutation research? | UT MD Anderson
    The most frequently mutated of these oncogenic driver genes, called KRAS, is associated with some of the most fatal cancer types: lung, pancreatic and colorectal cancers
  • Targeting KRAS mutations: orchestrating cancer evolution and . . .
    In this review, we provide a brief overview of KRAS mutations in cancers and tumorigenesis, specifically focusing on currently approved therapies for targeting KRAS, ongoing advances,
  • KRAS Mutations in Solid Tumors: Characteristics, Current Therapeutic . . .
    Kristen rat sarcoma (KRAS) gene is one of the most common mutated oncogenes in solid tumors Yet, KRAS inhibitors did not follow suit with the development of targeted therapy, for the structure of KRAS has been considered as being implausible to target for decades
  • KRAS gene: MedlinePlus Genetics
    The KRAS gene provides instructions for making a protein called K-Ras that is part of a signaling pathway known as the RAS MAPK pathway The protein relays signals from outside the cell to the cell's nucleus
  • Type of KRAS mutation may guide more effective cancer treatments
    Up to a third of patients with lung adenocarcinoma, the most common form of lung cancer, have KRAS mutations that are thought to be responsible for tumor development and growth
  • First-in-Class Investigational Drug KRAS G12D Degrader Shows Promise in . . .
    A new drug is showing promise in lung and pancreatic cancers — two of the most aggressive forms of cancer — by targeting one of the most common cancer-driving mutations Setidegrasib, formerly known as ASP3082, tags and destroys the cancer-causing protein produced by the KRAS G12D mutation This new method for targeting a long-known mutation is called a KRAS degrader KRAS mutations are
  • Exploring KRAS: A precision approach in oncology - MSD
    KRAS is one of the most frequently mutated oncogenes found in cancer In healthy cells, KRAS serves as an on-off switch that regulates cell growth However, when the gene is mutated, KRAS can become stuck in the “on” position, causing uncontrolled cancer cell growth and proliferation
  • KRAS Cancer Kickers
    KRAS is the most common biomarker associated with lung, colorectal, plus other cancers Find resources to help with treatment
  • Setidegrasib in Advanced Non–Small-Cell Lung Cancer and Pancreatic . . .
    The KRAS p G12D variant occurs in 5% of patients with non–small-cell lung cancer (NSCLC) and is the most common substitution variant in pancreatic ductal adenocarcinoma, occurring in 40% of





中文字典-英文字典  2005-2009